Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
- Registration Number
- NCT00534794
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 79
Inclusion Criteria
- Documented history of ocular allergy to cats.
- Positive skin prick allergen reaction to cat dander.
Exclusion Criteria
- Use of any topical or systemic corticosteroids, immunosuppressive agents, antihistamines, decongestants, NSAIDs, or asprin during the two weeks prior to enrollment into the study.
- History of severe asthma, reactive airway disease or bronchial obstruction.
- Ocular surgery or trauma in the last year.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pataday Pataday - Elestat Elestat -
- Primary Outcome Measures
Name Time Method Change in Ocular Itch Score From Baseline 0 hours, 12 hours Ocular itch was measured on a 0 (none) to 4 (severe itch with continual desire to rub eyes) scale. Negative values for change from baseline represent favorable outcomes.
- Secondary Outcome Measures
Name Time Method Ocular Comfort Score at 12 Hours 12 hours Ocular comfort was measured on a 0 (more uncomfortable) to 10 (more comfortable) scale.
Trial Locations
- Locations (1)
Ophthalmic Consultants of Boston
🇺🇸Boston, Massachusetts, United States